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Abstract Standardization of body fluid sampling, processing
and storage procedures is pivotal to ensure data quality in
metabolomics studies. Yet, despite strict adherence to standard
sampling guidelines, we detected variable levels of ethanol in
the 1H-NMR spectra of human cerebrospinal fluid (CSF) sam-
ples (range 9.2×10−3–10.0 mM). The presence of ethanol in
all samples and the wide range of concentrations clearly indi-
cated contamination of the samples of some sort, which af-
fected the 1H-NMR spectra quality and the interpretation. To
determine where in the sampling protocol the ethanol contam-
ination occurs, we performed a CSF sampling protocol simu-
lation with 0.9 % NaCl (saline) instead of CSF and detected
ethanol in all simulation samples. Ethanol diffusion through
air during sampling and preparation stages appeared the only
logical explanation. With a bench study, we showed that eth-
anol easily diffuses into ex vivo CSF samples via air transmis-
sion. Ethanol originated from routinely used skin disinfectants
containing ethanol and from laboratory procedures. Ethanol
affected the CSF sample matrix at concentrations above
~9.4 mM and obscured a significant part of the 1H-NMR
spectrum. CSF sample preparation for 1H-NMR-based meta-
bolomics analyses should therefore be carried out in a well-
ventilated atmosphere with laminar flow, and use of ethanol
should be avoided.
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Introduction
Cerebrospinal fluid (CSF) is generally believed to reflect brain
physiology and is therefore frequently used to assess bio-
markers for brain disorders [1–3]. CSF sampling, processing,
and storage procedures are pivotal to prevent biochemical
ex vivo changes which may invalidate the observed profiles.
Recently, a consensus protocol was published [4] to standard-
ize CSF sampling and storage for CSF biobanks. However,
despite rigorous adherence to this and other protocols, we
detected substantial amounts of ethanol disturbing the 1H-
NMR spectra of human CSF samples. Other studies reporting
the presence of ethanol in CSF have interpreted this as either a
contaminant [5, 6] or due to the disease process [7, 8].
In the present study, we set out to identify the origin of




The cohort in which we initially discovered ethanol contami-
nation consisted of human CSF samples that were collected
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for research purposes, namely to investigate the patho-
physiology of migraine. The study protocol was approved
by the Medical Ethical Committee of Leiden University
Medical Center (LUMC), and all subjects gave written
informed consent prior to collection. For disinfection of
the skin, chlorhexidine (5 g/L)/denatured ethanol 70 %
(Pharmacy LUMC, art. no.: 909602) was used. CSF sam-
ples were taken via lumbar puncture. Three different sam-
ple handling protocols were used simultaneously for the
preparation of samples for mass spectrometry (MS)-based
metabolomics (methods 1 and 2) and for 1H-NMR-based
metabolomics (method 3) (see Fig. 1). Method 3 was used
for the initial 1H-NMR measurements in which we detect-
ed ethanol contamination. For sampling of method 3,
4.8 mL of CSF dripped through air into a 15-mL polypro-
pylene falcon tube. Directly after sampling, the CSF was
centrifuged at 4 °C for 5 min (2000 rpm, 747 g). Follow-
ing centrifugation, the supernatant was transferred to a
15-mL polypropylene falcon tube and divided in 0.5-mL
aliquots, placed on dry ice within 30 min of sampling and
transferred to −80 °C for storage within 60 min of sam-
pling. In sampling methods 1 and 2, cold ethanol was
added to the CSF during the sample handling to denature
proteins and to be able to thaw the samples before mea-
surements at lower temperatures. Because this was a like-
ly source of ethanol contamination, we also analysed three
CSF samples obtained for clinical diagnostic purposes to
check whether ethanol is also present in these samples.
Disinfection of the skin with chlorhexidine (5 g/L)/dena-
tured ethanol 70 %, sample collection and sample pro-
cessing of these clinical samples were similar to the re-
search samples with the exception that ethanol was not
used anywhere in the handling of these samples. For
additional details on sampling and processing of the re-
search and clinical CSF samples, see the Electronic Sup-
plementary Material (ESM).
Simulation of CSF sampling protocol with saline
To determine the origin of ethanol during our sample process-
ing procedure, we performed a CSF sampling protocol simu-
lation. A 0.9 % NaCl solution (saline) was used instead of
CSF in an exact simulation of the CSF sampling protocol
(see Fig. 1). Different pipetting methods were used for mass
spectrometry (MS)-based metabolomics (methods 1 and 2)
and for 1H-NMR-basedmetabolomics (method 3). In methods
1 and 2, one pipette was used throughout the entire sampling
protocol, including pipetting of ethanol. In method 3, a differ-
ent pipette was used which had never been exposed to ethanol;
only these samples were measured with 1H-NMR as described
below.
Air to sample diffusion of ethanol
To test how fast ethanol can diffuse into CSF via air, we
created a work area simulation. Ethanol (1 mL, Biosolve,
96 % analytical grade) was placed into 2 × 1.8-mL
cryotubes (Nunc, art. no. 368632). An up-turned 500-mL
glass beaker was placed over two open cryotubes contain-
ing 1 mL of saline and one open cryotube containing etha-
nol (see Fig. 2a). After 5 min, one saline cryotube was
removed and capped firmly until 1H-NMR analysis. The
second cryotube was removed after 30 min. This process
was repeated without the beaker in the same well-ventilated
work space. All samples were then prepared for and
Fig. 1 In-house sample processing protocol used for preparation of
samples for mass spectrometry (MS)-based metabolomics (methods 1
and 2) and for 1H-NMR-based metabolomics (method 3). All aliquots
were immediately placed on dry ice within 30 min of sampling and then
transferred to −80 °C for storage within 60 min
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analysed by quantitative 1H-NMR spectroscopy as de-
scribed below.
Effect of ethanol on the sample matrix
A serial dilution was made to test at which level of ethanol
contamination the CSF matrix and thereby the whole 1H-
NMR spectrum is affected. Two hundred microlitres of CSF
was aliquoted into 10×1.5-mL eppendorf tubes containing
ethanol (Biosolve, 96 % analytical grade), decreasing in con-
centration in regular stepped increments so that the final eth-
anol concentrations were 9.1×10−3–500.0 mM. Samples were
prepared for 1H-NMR analysis as described below.
1H-NMR sample preparation
In 1.5-mL eppendorf tubes that were placed on ice, 225 μL of
CSF, 0.9 % NaCl, or CSF/ethanol was added to 25 μL of pH
7.0 phosphate buffer (50 mM) in D2O containing 4 mM of
sodium 3-trimethylsilyltetradeuteriopropionate (TSP) and
2.0 mMNaN3. Following thorough mixing by repeated inver-
sion, 190 μL of the sample was transferred into 3-mm NMR
tubes in a cooled rack at 6 °C.
1H-NMR data acquisition and processing
1H-NMR data were obtained using a Bruker 600 MHz AVAN
CE II spectrometer equipped with a 5-mm TCI cryoprobe and
a z-gradient system; a Bruker SampleJet sample changer sys-
tem was used for sample transfer; samples were kept at 6 °C
while queued for acquisition. One-dimensional (1D) 1H-NMR
spectra were recorded at 300.0 K using the first increment of a
NOESY pulse sequence [9] with presaturation (γB1=50 Hz)
during a relaxation delay of 4 s and a mixing time of 10 ms for
efficient water suppression [10]. The duration of 90° pulses
was automatically calibrated for each individual sample using
a homonuclear gated nutation experiment [11] on the locked
and shimmed samples after automatic tuning and matching of
the probe head. Sixteen scans of 200,704 points covering 18,
028 Hz were recorded and zero filled to 262,144 complex
points prior to Fourier transformation; an exponential window
function was applied with a line-broadening factor of 1.0 Hz.
The spectra were manually phased and baseline corrected and
automatically referenced to the internal standard (TSP=
0.0 ppm). Phase offset artifacts of the residual water resonance
were manually corrected using a polynomial of degree 5 least
square fit filtering of the free induction decay (FID) [12].
1H-NMR data analysis
Quantification of ethanol peaks was carried out by iterative
line fitting in the frequency domain (Topspin version 2.1,
Bruker Biospin; MDCON command).
Fig. 2 Cross-contamination of CSF by diffusion of ethanol through air. a
Schematic representation of experimental set-up to test for air diffusion of
ethanol. b 1H-NMR overlay spectrum showing the methyl signal of eth-
anol; here, it is used to visualize the relative amount of ethanol found in
test samples from the air diffusion experiment. c Table comparing the
amount of ethanol quantified in the air to sample diffusion test with the
simulation of CSF sampling protocol with saline, clinical CSF samples
and research CSF samples
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Results
Ethanol in human CSF samples
Ethanol was detected in 1H-NMR spectra of not only all re-
search CSF samples but also in three clinical CSF samples
where ethanol is only used during disinfection and not during
sample processing (see Fig. 2c). In the research samples, the
ethanol levels varied between 0.08 and 10.0 mM and, in the
three clinical samples, the ethanol levels were 9.2×10−3,
0.023 and 0.063 mM.
Simulation of CSF sampling protocol with saline
In the simulation experiment, ethanol was detected in all sam-
ples, even in method 3 (Fig. 1) in which no ethanol was used.
Furthermore, we observed a trend of increasing ethanol con-
centration from 0.070 to 0.203 mM (mean) in the aliquots of
method 3, which was related to the time the cryotubes were
uncapped during aliquoting. These findings suggested that the
ethanol arose from cross-contamination by air diffusion dur-
ing sampling and processing procedures.
Air to sample diffusion of ethanol
To test the hypothesis of ethanol diffusion through air, we
created a work area simulation. Ethanol readily diffused into
an open vessel containing saline. After 5 min under a beaker,
ethanol was detected at 0.82 mM compared to 7.2×10−3 mM
after 5 min open on the lab bench. After 30 min, ethanol had
increased to 2.5 and 0.055 mM, respectively (see Fig. 2b, c).
These levels are in the same range as the CSF and saline
samples prepared using sampling handling method 3 (see
Fig. 2c).
Effect of ethanol on the sample matrix
An effect of high ethanol concentrations on the CSF matrix
was demonstrated in a spiking experiment. A distinctive up-
field shift of small metabolite signals is observed at ethanol
concentrations of 9.38 mM and higher (Fig. 3).
Discussion
We showed that CSF samples can be contaminated with
ethanol during routine sampling and processing steps via
diffusion through air. Most likely sources of ethanol are (i)
disinfection of the skin with chlorhexidine/70 % ethanol
prior to lumbar puncture and (ii) use of ethanol in the same
room as where the CSF samples were prepared for 1H-NMR
measurements. Ethanol affected the CSF sample matrix at
concentrations above ~9.4 mM and obscured a significant
part of the 1H-NMR spectrum.
The most important effect of ethanol contamination is on
the interpretation of the 1H-NMR spectra. The two signal
groups of ethanol at 1.18 and 3.66 ppm can mask metabo-
lites that lie in the same chemical shift region of 1H-NMR
spectra. The methylene quartet at 3.66 ppm will itself be
masked, as it lies in the heavily crowded glucose region of
the spectrum. The methyl signal of the small metabolite 3-
hydroxybutyric acid, however, normally occurs in the same
region of the CSF spectrum as the ethanol methyl triplet
(1.18 ppm). In the presence of ethanol, the detection and
subsequent quantification of this metabolite are heavily
compromised.
There are several solutions to minimize the risk of ethanol
contamination and tomitigate its effects onmetabolomics anal-
ysis, as follows: 1) ethanol regions can sometimes be removed
from 1H-NMR spectra prior to multivariate analysis; 2)
Fig. 3 1H-NMR spectra overlay (a) and graph (b) showing the effect of ethanol on the chemical shift of the α-anomeric proton of D-glucose as an
example
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spectrum alignment might be required prior to analysis in cases
of severe matrix distortion; 3) processing of CSF samples for
1H-NMR analysis in an ethanol-free zone or well-ventilated
area such as a laminar flow cabinet; 4) use of non-ethanol-
containing disinfectant instead of chlorhexidine/ethanol.
We believe that the recommendations resulting from this
study should be considered when collecting CSF for biomark-
er research in brain disorders.
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